Kelly Godbout

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 9

Top Topics

Duchenne Muscular Dystrophy

Pluripotent Stem Cells

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Kelly Godbout, Jacques P Tremblay
Prime Editing for Human Gene Therapy: Where Are We Now? Cells 12 (4) (2023)
Kelly Godbout, Joël Rousseau, Jacques P Tremblay
Successful Correction by Prime Editing of a Mutation in the RYR1 Gene Responsible for a Myopathy. Cells 13 (1) (2023)
Kelly Godbout, Joël Rousseau, Jacques P Tremblay
Successful Correction by Prime Editing of a Mutation in the RYR1 Gene Responsible for a Myopathy. Cells 13 (1) (2023)
Kelly Godbout, Jacques P Tremblay
Prime Editing for Human Gene Therapy: Where Are We Now? Cells 12 (4) (2023)
Kelly Godbout, Joël Rousseau, Jacques P Tremblay
Successful Correction by Prime Editing of a Mutation in the RYR1 Gene Responsible for a Myopathy. Cells 13 (1) (2023)
Kelly Godbout, Joël Rousseau, Jacques P Tremblay
Successful Correction by Prime Editing of a Mutation in the RYR1 Gene Responsible for a Myopathy. Cells 13 (1) (2023)
Kelly Godbout, Jacques P Tremblay
Prime Editing for Human Gene Therapy: Where Are We Now? Cells 12 (4) (2023)
Kelly Godbout, Joël Rousseau, Jacques P Tremblay
Successful Correction by Prime Editing of a Mutation in the RYR1 Gene Responsible for a Myopathy. Cells 13 (1) (2023)
Kelly Godbout, Jacques P Tremblay
Delivery of RNAs to Specific Organs by Lipid Nanoparticles for Gene Therapy. Pharmaceutics 14 (10) (2022)